![Page 1: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/1.jpg)
EuroPrevent 2010Fatal versus total events in risk assessment models
Pekka Jousilahti, MD, PhD,Research Professor
National Institute for Health and Welfare, Finland
![Page 2: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/2.jpg)
Risk assessment models
• Estimates the risk of an event or death based on levels of selected risk factors
• Needed;
– To demonstrate the risk to the patient
– To motivate for lifestyle changes
– To assess the need for drug treatment in clinical practice
11/05/2010 Pekka Jousilahti, THL 2
![Page 3: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/3.jpg)
Absolute risk
Depends on;
• Age and gender
• Population (low- vs. high risk populations)
– Time of baseline measurements
• Selected risk factors in the model
– Printed table vs. computerized systems
• Length of follow-up
• Endpoint– Mortality vs. total events
– CHD, stroke, any CVD event
11/05/2010 Pekka Jousilahti, THL 3
![Page 4: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/4.jpg)
Factors explaining CVD mortality
• Non-modifiable risk factors– Age, gender, genes
• Known modifiable risk factors– Smoking, lipid abnormalities (total and HDL
cholesterol), high blood pressure, diabetes, low physical activity, obesity
• Other/putative risk factors– Hemostatic and inflammatory factors, number of
dietary factors …. more than one hundred??
• Treatment– Secondary prevention: statins, beta-blockers, ACE
inhibitors, ASA
– Invasive treatment: trombolysis, angioplasty, coronary surgery
![Page 5: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/5.jpg)
Different risk assessment models
• Framingham: Classic - many versions
• SCORE: the European standard
• PRECARD: Sophisticated electronic
• FINRISK Score: National tool
11/05/2010 Pekka Jousilahti, THL 5
![Page 6: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/6.jpg)
Framingham
• Small American town (about 60000 inhabitants)
• First baseline data collection started 1948
• Different versions
– Example based on the follow-up of 2590 men and 2983 women aged 30-74 years at baseline (original cohort + Framingham Offspring Study cohort)
• 10-year follow-up
• End-point: all CVD events (including non-hospitalized patients and MIs based on ECG findings without marked symptoms)
• Published in different versions and technical solutions
11/05/2010 Pekka Jousilahti, THL 6
![Page 7: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/7.jpg)
SCORE
• The function is based on the follow-up of 12 European cohorts
• Baseline data collection between 1969 and 1988– 117098 men and 88080 women
• Age, sex, smoking, total cholesterol, systolic blood pressure
– Sub-sample: Diabetes, HDL cholesterol, family history
• Baseline risk calculated separately for southern (low-risk) and northern (high risk) cohorts
• End-point: death from CHD or other atherosclerotic CVD
11/05/2010 Pekka Jousilahti, THL 7
![Page 8: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/8.jpg)
![Page 9: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/9.jpg)
Ten-year CHD risk among Finnish men, 50 years of age (%)
0
2
4
6
8
10
12
14
16
18
20 No risk factors
Smoking
High BP
DM
High serum cholesterol
Smoking and BP
Smoking and DM
Smoking and cholesterol
Cholesterol and DM
BP and DM
Cholesterol and BP
Smoking, BP and DM
Smoking, cholesterol, DM
Cholesterol, BP, DM
All four risk factorsSystolic blood pressure 160 mmHg, serum cholesterol 7 mmol/l
![Page 10: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/10.jpg)
Ten-year CHD risk among Finnish women, 50 years of age (%)
0
1
2
3
4
5
6
7 No risk factors
Cholesterol
BP
Smoking
DM
Smoking and cholesterol
Smoking and BP
Cholesterol and BP
Cholesterol and DM
smoking and DM
BP and DM
Column 15
Smoking, cholesterol, BP
Cholesterol, BP, DM
Smoking, BP, DM
All four risk factors
Systolic blood pressure 160 mmHg, cholesterol 7 mmol/l
![Page 11: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/11.jpg)
FINRISK Score
• Follow-up of FINRISK 1982, 1987 and 1992 cohorts
– 9391 men and 10056 women aged 25-64 and free of symptomatic CHD at baseline
• Follow-up based on national hospital discharge and cause of death registers
• End-point: MI, unstable angina pectoris (needing hospitalization) and CHD death
– cerebrovascular events (both ischemic and hemorrhachig) needing hospitalization and stroke deaths
• Computer-based calculator in web – for both for health professionals and general public
11/05/2010 Pekka Jousilahti, THL 11
![Page 12: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/12.jpg)
FINRISK Score
http://www.ktl.fi/portal/suomi/osastot/eteo/tutkimus/riskipiste/finriski-laskuri/
![Page 13: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/13.jpg)
11/05/2010 Pekka Jousilahti, THL 13
![Page 14: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/14.jpg)
Average 10-year risk for CVD event or death (FINRISK 2007 population)
FINRISK SCORE FRAMINGHAM
MEN
CHD 3,4 2,7 9,3
Stroke 2,3 0,9 2,1
CVD 5,7 3,5 13,5
WOMEN
CHD 1,1 0,6 3,9
Stroke 1,1 0,4 1,3
CVD 2,2 1,0 6,7
11/05/2010 Pekka Jousilahti, THL 14
![Page 15: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/15.jpg)
Ten-year CVD risk by age
11/05/2010 Pekka Jousilahti, THL 15
![Page 16: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/16.jpg)
Ten-year CHD risk by age
11/05/2010 Pekka Jousilahti, THL 16
![Page 17: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/17.jpg)
Ten-year stroke risk by age
11/05/2010 Pekka Jousilahti, THL 17
![Page 18: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/18.jpg)
Fatal vs. total risk assessment
• CVD death
– clear and fairly reliable
– international comparations
– underestimates the “true” CVD risk
– can not make difference between primary prevention and treatment
• Total CVD events
– preferable
– national data available in many countries
– risk prediction depends on end-point definition
• Risk “equivalents”
– SCORE 5%
– FINRISK: 10%
– Framingham 20%
11/05/2010 Pekka Jousilahti, THL 18
![Page 19: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/19.jpg)
Ten-year CVD risk by age
11/05/2010 Pekka Jousilahti, THL 19
![Page 20: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/20.jpg)
Mr X
• Age 55 yrs, SBP 140mmHg, total cholesterol 5.0 mmol/l, non-smoker – fine!
• 10- year risk
– SCORE 3%
11/05/2010 Pekka Jousilahti, THL 20
![Page 21: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/21.jpg)
Mr X
• But he has diabetes, parents have had MI, HDL cholesterol 1.0 mmol/l
• 10- year risk
– FINRISK 16%!
11/05/2010 Pekka Jousilahti, THL 21
![Page 22: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/22.jpg)
Absolute vs. relative risk
• Absolute risk is generally low in young people
– life time risk
– risk projection to higher age (with same risk factors)
• Motivation for lifestyle changes
– both absolute and relative risk can be used
• Drug treatment
– assessment should be mainly based on absolute risk
– total risk assessment (including major risk factors and end-points)• Should men and women have different guidelines for hyprertension
and cholesterol treatment? How about smokers and non-smokers?
– side effects and costs are absolute
11/05/2010 Pekka Jousilahti, THL 22
![Page 23: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/23.jpg)
Conclusions
• There are no objective definition for “high” risk
– depends on age, gender - and values of the individuals and society
– The specificity and sensitivity of the test depends on arbitrary decision
– Health economic calculations; cost of healthy life year, saved life year, DALY….
• In clinical practice (and public health projects) differences in end-point definitions should be taken into account in risk assessment
11/05/2010 Pekka Jousilahti, THL 23
![Page 24: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/24.jpg)
Acknowledgements
• Prof. Erkki Vartiainen
• Ass. prof. Tiina Laatikainen
• Ass. prof. Markku Peltonen
• Prof. Veikko Salomaa
• Literature:– SCORE: Conroy RM et al, Estimation of ten-year risk of fatal
cardiovascular disease in Europe: the SCORE Project. Eur Heart J 2003;24:987-1003.
– Framingham: Anderson KM et al, Updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356-362.
11/05/2010 Pekka Jousilahti, THL 24
![Page 25: EuroPrevent 2010 Fatal versus total events in risk ...assets.escardio.org/assets/presentations/epr2010/429.pdf · EuroPrevent 2010 Fatal versus total events in risk assessment models](https://reader031.vdocuments.mx/reader031/viewer/2022011903/5f120d1d6cda786f0d732468/html5/thumbnails/25.jpg)
THANK YOU